ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

New Two-Step Matching Process Increases Success of Transplants

September 30, 2011

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

Science Fellowships Available; Grants For Former Soviet Scientists

August 16, 1996

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007